At this time, posts about Youngjin Pharm are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 73,785 shares of Youngjin Pharm, and institutions have purchased a net 2,000 shares. Youngjin Pharm is known as a leading pharmaceutical company specializing in prescription drugs affiliated with KT&G.


As of 12:30 PM on the 22nd, Youngjin Pharm's stock price is 9,210 KRW, up 7.22% from the previous day, with a trading volume of 50,281,571 shares, which is 1,202.49% of the 5-day average trading volume.


In addition to Youngjin Pharm, posts by investors are also rapidly increasing for Kyungbo Pharmaceutical (214390), GL Pharmtech (204840), and Daehan Scientific (131220).



※ Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing